TA treatment at both doses reduced concentrations of MMP-2 in both ascites macrophages and tumor cells, with a more pronounced effect observed in ascites macrophages (p < 0.001 for both doses) than in tumor cells (p < 0.05 for both doses). The gene discussed is MMP2; the disease is neoplasm.